With the sun setting on criminalized cannabis in Canada, one local dispensary owner is hoping he can come out of the shadows as legalization dawns.

Former municipal councillor and owner of 99 North Medical Cannabis Dispensary, Bryan Raiser is hoping to relocate to the old liquor store location, in Squamish Station Shopping Centre.

Raiser’s current location at the end of Second Avenue isn’t great for customer parking and isn’t central, he told The Chief.

The new location, at 1200 Hunter Place, has plenty of parking and is more visible.

Location in Squamish Station where Raiser hopes to relocate. - Google Maps

Aurora Cannabis Inc. ("Aurora" or the "Company") (TSX: ACB) (OTCQB: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) and CTT Pharmaceutical Holdings Inc. ("CTT") (US-OTC: CTTH) today announced that Aurora is acquiring an initial 9.14% ownership interest in CTT via way of a non-brokered private placement in the form of a US$1 million 5% convertible debenture. The agreement includes an issuance of warrants enabling to Aurora to increase ownership to 42.5%.

Commercial agreement

As marijuana farmers in Oregon say a flood of supply is killing their businesses less than three years after recreational cannabis was legalized, economists say it's a warning to Canada.

Stephen Easton, professor of economics at Simon Fraser University and senior fellow at the Fraser Institute, says large fluctuations in price and supply are bound to happen when you create a legal market where an illegal market already exists.

"There is no reason to think it won't happen here as well. In a broader sense, we are adding legal production to an already robust illegal production," Easton said.

"Consumption may simply not increase in proportion to our ability to grow."

When Canada legalizes marijuana later this summer, the big players say they will be ready to do business — and this week, one of them got much bigger.

Aurora Cannabis announced on Monday that the company will buy medical marijuana firm MedReleaf for $3.2 billion to create an industrial giant with a valuation of about $7 billion.

For a very long time, Canopy Growth Corp. (TSX:WEED) has been the top dog in Canada’s burgeoning marijuana industry. But thanks to recent moves by emerging competition, is that still a safe assumption to hold? Canopy Growth was one of Canada’s first licensed medical marijuana producers and one of the first companies to come to the market with an initial public offering (IPO) around the time that speculation began that soon-to-be-elected prime minister Justin Trudeau would be making a push to legalize cannabis use for recreational purposes. Thanks to some pretty emphatic enthusiasm from both cannabis supporters as well as capitalists…

Facility plans to produce 25 to 30 times more cannabis, create up to 200 jobs.

Canada's Island Garden in Charlottetown is growing its business by more than it originally planned. The P.E.I. marijuana grower is building a new greenhouse and warehouse, at a cost of $35 million.

"It's a very exciting day for me today," said Edwin Jewell, the company's president and CEO.

"I'm very pleased and very proud to think that what started out as an idea just a few years ago has turned into a successful company."

New capital

Biome Grow says its 100 per cent-owned Newfoundland and Labrador-based subsidiary, The Back Home Medical Cannabis Corporation, expects to complete construction of its first in-province cannabis production facility in 2018.

Back Home is a late-stage applicant under Canada’s Access to Cannabis for Medical Purposes Regulations, according to a prepared release from Biome.

Biome acquired Back Home April 25, however Biome’s construction and design teams have been working on this project since December of 2017.

Biome and Back Home anticipate being in a position to grow cannabis in 2018 from its first production facility located in Barachois Brook, subject to Back Home’s receipt of a cultivation licence from Health Canada.

INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTC: IVITF; FRA: 8IS1) is pleased to announce that Acreage Pharms Ltd. ("Acreage Pharms") has received its sales license from Health Canada pursuant to the Access to Cannabis for Medical Purposes Regulations (ACMPR) effective May 18, 2018.

After getting licence to export medical cannabis, company plans 1st shipment to Australia.

Organigram, the Moncton-based medical cannabis company, is taking its business international, which could mean more jobs in New Brunswick down the road. 

The company has received a licence from Health Canada to export its products.

Organigram said it plans to send its first shipment to Australia next week.

It also recently signed a contract for an equity stake in a German medical cannabis company.

Ray Gracewood, chief commercial officer for Organigram, told Information Morning Moncton the international market presents a "massive" opportunity to grow the company.

Jessika Villano sells a potent array of dried cannabis, oils, salves and even bud-infused bath bombs at Buddha Barn Medicinal Society -- all grown and processed by small-scale British Columbia producers.

Villano doesn't want that to change when marijuana is legalized later this year, and she's among the proponents of local craft cannabis who are pushing the federal and provincial governments to ensure its survival.

"I believe in our sector," Villano said. "Our elected representatives need to take immediate steps to protect it or face the consequences of letting B.C. craft cannabis collapse."